BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18095031)

  • 21. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
    Suzuki T; Matsuo K; Sawaki A; Mizuno N; Hiraki A; Kawase T; Watanabe M; Nakamura T; Yamao K; Tajima K; Tanaka H
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2742-7. PubMed ID: 18843018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer.
    Zhang BL; Sun T; Zhang BN; Zheng S; Lü N; Xu BH; Wang X; Chen GJ; Yu DK; Lin DX
    Chin Med J (Engl); 2011 Jan; 124(2):199-204. PubMed ID: 21362365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics of capecitabine in advanced breast cancer patients.
    Largillier R; Etienne-Grimaldi MC; Formento JL; Ciccolini J; Nebbia JF; Ginot A; Francoual M; Renée N; Ferrero JM; Foa C; Namer M; Lacarelle B; Milano G
    Clin Cancer Res; 2006 Sep; 12(18):5496-502. PubMed ID: 17000685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.
    Stoehlmacher J; Goekkurt E; Mogck U; Aust DE; Kramer M; Baretton GB; Liersch T; Ehninger G; Jakob C
    Cancer Lett; 2008 Dec; 272(2):221-5. PubMed ID: 18722050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
    Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
    Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
    Justenhoven C; Hamann U; Pierl CB; Rabstein S; Pesch B; Harth V; Baisch C; Vollmert C; Illig T; Brüning T; Ko Y; Brauch H
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3015-8. PubMed ID: 16365030
    [No Abstract]   [Full Text] [Related]  

  • 29. Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy.
    Edvardsen H; Kristensen VN; Grenaker Alnaes GI; Bøhn M; Erikstein B; Helland A; Børresen-Dale AL; Fosså SD
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1163-71. PubMed ID: 17336217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
    Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
    Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment.
    Zárate R; González-Santigo S; de la Haba J; Bandres E; Morales R; Salgado J; Gómez A; Aranda E; García-Foncillas J
    Curr Drug Metab; 2007 Jun; 8(5):481-6. PubMed ID: 17584018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy.
    Yokomizo A; Yamamoto K; Kinukawa N; Tsunoda T; Koga H; Naito S
    Int J Urol; 2007 Jun; 14(6):500-4. PubMed ID: 17593093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity.
    Jakobsen A; Nielsen JN; Gyldenkerne N; Lindeberg J
    J Clin Oncol; 2005 Mar; 23(7):1365-9. PubMed ID: 15735113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of methylenetetrahydrofolate reductase and thymidylate synthase enhancer region polymorphisms on the risk of idiopathic recurrent spontaneous abortion in a Korean population.
    Bae J; Choi DH; Kang MS; Cha SH; Oh D; Kim NK
    Fertil Steril; 2009 Apr; 91(4 Suppl):1560-2. PubMed ID: 18990369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.
    Kawakami K; Graziano F; Watanabe G; Ruzzo A; Santini D; Catalano V; Bisonni R; Arduini F; Bearzi I; Cascinu S; Muretto P; Perrone G; Rabitti C; Giustini L; Tonini G; Pizzagalli F; Magnani M
    Clin Cancer Res; 2005 May; 11(10):3778-83. PubMed ID: 15897576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.
    Giovannetti E; Ugrasena DG; Supriyadi E; Vroling L; Azzarello A; de Lange D; Peters GJ; Veerman AJ; Cloos J
    Leuk Res; 2008 Jan; 32(1):19-24. PubMed ID: 17395259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.
    Schwab M; Zanger UM; Marx C; Schaeffeler E; Klein K; Dippon J; Kerb R; Blievernicht J; Fischer J; Hofmann U; Bokemeyer C; Eichelbaum M;
    J Clin Oncol; 2008 May; 26(13):2131-8. PubMed ID: 18299612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss.
    Vettriselvi V; Vijayalakshmi K; Paul SF; Venkatachalam P
    J Obstet Gynaecol Res; 2008 Jun; 34(3):301-6. PubMed ID: 18588608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.